SCHEMBL14153100

SCHEMBL14153100

CCC(CC)c1nc(-c2ccc(-c3ccncc3)cc2)no1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 10/20 0.62
NPC1 O15118 8/20 0.55
RAB9A P51151 8/20 0.55
MAPT P10636 5/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
ALDH1A1 P00352 4/20 0.55
LMNA P02545 3/20 0.55
TP53 P04637 2/20 0.55
NFKB1 P19838 2/20 0.51
NFKB2 Q00653 2/20 0.51
RELA Q04206 2/20 0.51
HSD17B10 Q99714 2/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
S1PR3 Q99500 4/20 0.51
NPSR1 Q6W5P4 3/20 0.50
TSHR P16473 2/20 0.49
HPGD P15428 2/20 0.48
TTR P02766 1/20 0.48
HTT P42858 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19090054 0.97 S1PR1 (0.66) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14061787 0.87 S1PR1 (0.52) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14153146 0.86 S1PR1 (0.61) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14153246 0.86 S1PR1 (0.61) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL24325675 0.85 NPC1 (0.53) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14153256 0.84 S1PR1 (0.50) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14153795 0.84 S1PR1 (0.47) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14060225 0.84 RAB9A (0.53) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL26524272 0.84 S1PR1 (0.48) S1PR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL19091431 0.83 S1PR1 (0.61) S1PR1NPC1RAB9AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012162635-A1 METABOTROPIC GLUTAMATE RECEPTORS 5 MODULATORS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2012-11-29 WO disclosed